Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Frontdoor
FTDR
$5.87B
| $79M | 0.07% |
1,626,718
+1,039,523
| +177% | +$50.2M |
|
352
Sunstone Hotel Investors
SHO
$2.01B
| $79M | 0.07% |
5,746,317
+486,800
| +9% | +$6.53M |
|
353
KB Home
KBH
$3.47B
| $78.9M | 0.07% |
2,320,390
-552,200
| -19% | -$15.5M |
|
354
Viavi Solutions
VIAV
$10.5B
| $78.4M | 0.07% |
5,597,288
+1,155,200
| +26% | +$16.4M |
|
355
IAMGOLD
IAG
$10.4B
| $78.4M | 0.07% |
22,986,200
+724,000
| +3% | +$2.6M |
|
|
PGRE
356
DELISTED
Paramount Group
PGRE
| $78.4M | 0.07% |
5,868,999
+769,700
| +15% | +$10.4M |
|
|
WNS
357
DELISTED
WNS Holdings
WNS
| $78.1M | 0.07% |
1,329,900
+74,100
| +6% | +$4.52M |
|
358
Ferrari
RACE
$71.5B
| $78M | 0.07% |
+506,043
| New | +$80.7M |
|
359
SiriusXM
SIRI
$9.54B
| $77.9M | 0.07% |
1,245,613
+1,158,147
| +1,324% | +$71.2M |
|
|
VER
360
DELISTED
VEREIT, Inc.
VER
| $77.5M | 0.07% |
1,585,318
+337,147
| +27% | +$15.9M |
|
361
Arista Networks
ANET
$263B
| $77.2M | 0.07% |
5,172,800
-2,699,200
| -34% | -$41.8M |
|
362
Factset
FDS
$9.93B
| $77.1M | 0.07% |
317,450
-148,350
| -32% | -$41.2M |
|
|
CZR
363
DELISTED
Caesars Entertainment Corporation
CZR
| $77M | 0.07% |
6,601,885
+4,883,300
| +284% | +$57.3M |
|
364
Ross Stores
ROST
$80.2B
| $76.9M | 0.07% |
700,228
+220,700
| +46% | +$23.3M |
|
365
Tandem Diabetes Care
TNDM
$1.6B
| $76.3M | 0.06% |
1,293,627
+395,700
| +44% | +$25.3M |
|
366
Perdoceo Education
PRDO
$1.94B
| $76.2M | 0.06% |
4,798,563
+423,801
| +10% | +$8.32M |
|
367
Evertec
EVTC
$1.81B
| $76M | 0.06% |
2,435,501
+236,500
| +11% | +$7.92M |
|
|
AUY
368
DELISTED
Yamana Gold, Inc.
AUY
| $75.9M | 0.06% |
23,872,281
+8,719,991
| +58% | +$27.8M |
|
369
Honda
HMC
$40.6B
| $75.8M | 0.06% |
2,906,800
+797,700
| +38% | +$20.1M |
|
370
National Health Investors
NHI
$3.49B
| $75.3M | 0.06% |
913,500
+21,000
| +2% | +$1.71M |
|
|
ISCA
371
DELISTED
International Speedway Corp
ISCA
| $75.2M | 0.06% |
1,671,286
+229,445
| +16% | +$10.3M |
|
372
Weyerhaeuser
WY
$17.8B
| $74.3M | 0.06% |
2,680,740
+1,516,200
| +130% | +$39.6M |
|
373
Baidu
BIDU
$35.2B
| $74.2M | 0.06% |
+721,700
| New | +$77.5M |
|
374
Qorvo
QRVO
$8.52B
| $73.8M | 0.06% |
994,906
+465,600
| +88% | +$33.8M |
|
375
First Industrial Realty Trust
FR
$8.4B
| $73.5M | 0.06% |
1,856,800
-664,200
| -26% | -$25.5M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.